Testing effectiveness (Phase 2)UnknownNCT03022734What this trial is testingShort Course Radiotherapy, Unresectable Rectal Cancer, Liver MetastasisWho this might be right forRectal Cancer, Metastatic Yonsei University 40
Early research (Phase 1)Ended earlyNCT00072098What this trial is testingInterleukin-12 Gene in Treating Patients With Liver Metastases Secondary to Colorectal CancerWho this might be right forColorectal CancerMetastatic Cancer Max Sung 22
Large-scale testing (Phase 3)Study completedNCT00062426What this trial is testingOxaliplatin and Bevacizumab (Avastin™) With Either Fluorouracil and Leucovorin or Capecitabine in Treating Patients With Advanced Colorectal CancerWho this might be right forColorectal Cancer Prologue Research International
Testing effectiveness (Phase 2)Looking for participantsNCT05868226What this trial is testingPRE-ISPY Phase I/II Oncology Platform ProgramWho this might be right forHER2-positive Breast CancerMetastatic CancerMetastatic Breast Cancer+29 more QuantumLeap Healthcare Collaborative 280
Not applicableUnknownNCT02554448What this trial is testingDetection of CTCs in Stage III Rectal Cancer Patients Undergoing Neoadjuvant TherapyWho this might be right forRectal NeoplasmsCirculating Tumor Cells Sixth Affiliated Hospital, Sun Yat-sen University 80
Testing effectiveness (Phase 2)UnknownNCT00006115What this trial is testingCombination Chemotherapy in Treating Patients With Metastatic Colorectal CancerWho this might be right forColorectal Cancer GERCOR - Multidisciplinary Oncology Cooperative Group
Testing effectiveness (Phase 2)Study completedNCT01131078What this trial is testingAvastin (Bevacizumab) in Combination Chemotherapy in Patients With Metastatic Cancer of the Colon or RectumWho this might be right forColorectal Cancer Hoffmann-La Roche 306
Testing effectiveness (Phase 2)Ended earlyNCT00052585What this trial is testingGefitinib and Combination Chemotherapy in Treating Patients With Advanced or Recurrent Colorectal CancerWho this might be right forAdenocarcinoma of the ColonAdenocarcinoma of the RectumMucinous Adenocarcinoma of the Colon+7 more National Cancer Institute (NCI) 50
Early research (Phase 1)Study completedNCT03251378What this trial is testingA Multi-Center, Open-Label Study of Fruquintinib in Solid Tumors and Colorectal, and Breast CancersWho this might be right forAdvanced Solid TumorsMetastatic Colon CancerMetastatic Breast Cancer+4 more Hutchison Medipharma Limited 129
Early research (Phase 1)Active Not RecruitingNCT05462717What this trial is testingDose Escalation and Dose Expansion Study of RMC-6291 Monotherapy in Subjects With Advanced KRASG12C Mutant Solid TumorsWho this might be right forNon-Small Cell Lung Cancer (NSCLC)Colorectal Cancer (CRC)Pancreatic Ductal Adenocarcinoma+1 more Revolution Medicines, Inc. 222
Early research (Phase 1)Study completedNCT01254617What this trial is testingLenalidomide and Cetuximab in Treating Patients With Advanced Colorectal Cancer or Head and Neck CancerWho this might be right forRecurrent Colon CarcinomaRecurrent Hypopharyngeal Squamous Cell CarcinomaRecurrent Laryngeal Squamous Cell Carcinoma+39 more National Cancer Institute (NCI) 24
Large-scale testing (Phase 3)UnknownNCT00337389What this trial is testingPhase III Randomized Study of 5-FU, CoFactor, and Avastin vs. 5-FU, LV and Avastin for First-Line Colorectal Cancer.Who this might be right forMetastatic Colorectal CancerColon CancerRectal Cancer Mast Therapeutics, Inc. 1,200
Testing effectiveness (Phase 2)Looking for participantsNCT07407465What this trial is testingUpfront Trastuzumab-Deruxtecan Plus Capecitabine and Bevacizumab for Patients With HER-2 Positive Metastatic Colorectal Cancer.Who this might be right forColorectal CancerColorectal AdenocarcinomaRectal Adenocarcinoma+4 more Gruppo Oncologico del Nord-Ovest 42
Large-scale testing (Phase 3)Study completedNCT00238381What this trial is testingRectal Reconstruction in Treating Patients Who Are Undergoing Surgery for Rectal CancerWho this might be right forColorectal Cancer Swiss Cancer Institute 336
Large-scale testing (Phase 3)Active Not RecruitingNCT05141721What this trial is testingA Patient-Specific Neoantigen Vaccine in Combination With Immune Checkpoint Blockade for Patients With Metastatic Colorectal CancerWho this might be right forColorectal Neoplasms Seattle Project Corporation 700
Testing effectiveness (Phase 2)Looking for participantsNCT06051695What this trial is testingEvaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 ExpressionWho this might be right forSolid Tumor, AdultColorectal CancerNSCLC+17 more A2 Biotherapeutics Inc. 474
Early research (Phase 1)WithdrawnNCT01605344What this trial is testingCrossover Evaluation of Effect of Atorvastatin on PK of Irinotecan in CRC Patients Receiving FOLFIRIWho this might be right forAdvanced Adenocarcinoma of the Colon or Rectum UNC Lineberger Comprehensive Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00040599What this trial is testingSafety Study of 90Y-hMN14 to Treat Colorectal CancerWho this might be right forColorectal CancerColon CancerRectal Cancer+3 more Gilead Sciences 72
Early research (Phase 1)Study completedNCT00084721What this trial is testingIrinotecan and Celecoxib in Treating Patients With Unresectable or Metastatic Colorectal CancerWho this might be right forColorectal CancerDiarrhea Roswell Park Cancer Institute 2
Testing effectiveness (Phase 2)Study completedNCT00094809What this trial is testingChemotherapy Administered Every 2 Weeks With or Without Pegfilgrastim in Subjects With Advanced or Metastatic Colon CancerWho this might be right forColon CancerColorectal CancerRectal Cancer Amgen 252